Surgical Outcomes and Quality Improvement Center, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Surgical Outcomes and Quality Improvement Center, Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL; Surgery Service, Jesse Brown VA Medical Center, Chicago, IL.
Surgery. 2021 Feb;169(2):240-247. doi: 10.1016/j.surg.2020.09.006. Epub 2020 Oct 17.
Guidelines recommend extended chemoprophylaxis for venous thromboembolism in high-risk patients having operations for inflammatory bowel disease. Quantifying patients' risk of venous thromboembolism, however, remains challenging. We sought (1) to identify factors associated with postdischarge venous thromboembolism in patients undergoing colorectal resection for inflammatory bowel disease and (2) to develop a postdischarge venous thromboembolism risk calculator to guide prescribing of extended chemoprophylaxis.
Patients who underwent an operation for inflammatory bowel disease from 2012 to 2018 were identified from the American College of Surgeons National Surgical Quality Improvement Program for colectomy and proctectomy procedure targeted modules. Postdischarge venous thromboembolism included pulmonary embolism or deep vein thrombosis diagnosed after discharge from the index hospitalization. Multivariable logistic regression estimated the association of patient/operative factors with postdischarge venous thromboembolism. A postdischarge venous thromboembolism risk calculator was subsequently constructed.
Of 18,990 patients, 199 (1.1%) developed a postdischarge venous thromboembolism within the first 30 postoperative days. Preoperative factors associated with postdischarge venous thromboembolism included body mass index (1.9% with body mass index ≥35 vs 0.8% with body mass index 18.5-24.9; odds ratio 2.34 [95% confidence interval 1.49-3.67]), steroid use (1.3% vs 0.7%; odds ratio 1.91 [95% confidence interval 1.37-2.66]), and ulcerative colitis (1.5% vs 0.8% with Crohn's disease; odds ratio 1.76 [95% confidence interval 1.32-2.34]). Minimally invasive surgery was associated with postdischarge venous thromboembolism (1.2% vs 0.9% with open; odds ratio 1.42 [95% confidence interval 1.05-1.92]), as was anastomotic leak (2.8% vs 1.0%; odds ratio 2.24 [95% confidence interval 1.31-3.83]) and ileus (2.1% vs 0.9%; odds ratio 2.60 [95% confidence interval 1.91-3.54]). The predicted probability of postdischarge venous thromboembolism ranged from 0.2% to 14.3% based on individual risk factors.
Preoperative, intraoperative, and postoperative factors are associated with postdischarge venous thromboembolism after an operation for inflammatory bowel disease. A postdischarge venous thromboembolism risk calculator was developed which can be used to tailor extended venous thromboembolism chemoprophylaxis by individual risk.
指南建议对因炎症性肠病而行手术的高危患者进行静脉血栓栓塞症的延长化学预防。然而,量化患者静脉血栓栓塞症的风险仍然具有挑战性。我们旨在:(1)确定与炎症性肠病患者接受结直肠切除术出院后静脉血栓栓塞症相关的因素;(2)开发一个出院后静脉血栓栓塞症风险计算器,以指导延长化学预防的处方。
从美国外科医师学院国家外科质量改进计划中,对 2012 年至 2018 年间因炎症性肠病而行结直肠切除术和直肠切除术靶向模块的患者进行了识别。出院后静脉血栓栓塞症包括出院后诊断的肺栓塞或深静脉血栓形成。多变量逻辑回归估计了患者/手术因素与出院后静脉血栓栓塞症的关联。随后构建了一个出院后静脉血栓栓塞症风险计算器。
在 18990 例患者中,199 例(1.1%)在术后 30 天内发生了出院后静脉血栓栓塞症。与出院后静脉血栓栓塞症相关的术前因素包括体重指数(体重指数≥35 的患者为 1.9%,体重指数为 18.5-24.9 的患者为 0.8%;比值比 2.34[95%置信区间 1.49-3.67])、类固醇使用(1.3%与 0.7%;比值比 1.91[95%置信区间 1.37-2.66])和溃疡性结肠炎(1.5%与克罗恩病 0.8%;比值比 1.76[95%置信区间 1.32-2.34])。微创手术(与开放手术相比为 1.2%与 0.9%;比值比 1.42[95%置信区间 1.05-1.92])、吻合口漏(与 1.0%相比为 2.8%;比值比 2.24[95%置信区间 1.31-3.83])和肠梗阻(与 0.9%相比为 2.1%;比值比 2.60[95%置信区间 1.91-3.54])与出院后静脉血栓栓塞症相关。根据个体危险因素,出院后静脉血栓栓塞症的预测概率范围为 0.2%至 14.3%。
炎症性肠病手术后,术前、术中及术后因素与出院后静脉血栓栓塞症相关。开发了一种出院后静脉血栓栓塞症风险计算器,可以根据个体风险来定制延长静脉血栓栓塞症化学预防。